COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAI, XING, GRESHOCK, THOMAS, STEVENSON, HEATHER, LIU, HONG, SANDERS, JOHN, MILLER, MICHAEL, MCCAULEY, JOHN, A, KERN, JONATHAN, HARRIS, JOEL, M, BASU, KALLOL, SCOTT, JACK, DEMONG, DUANE, STAMFORD, ANDREW, W, POIRIER, MARC, NEUSTADT, BERNARD
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DAI, XING
GRESHOCK, THOMAS
STEVENSON, HEATHER
LIU, HONG
SANDERS, JOHN
MILLER, MICHAEL
MCCAULEY, JOHN, A
KERN, JONATHAN
HARRIS, JOEL, M
BASU, KALLOL
SCOTT, JACK
DEMONG, DUANE
STAMFORD, ANDREW, W
POIRIER, MARC
NEUSTADT, BERNARD
description The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2964221A4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2964221A4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2964221A43</originalsourceid><addsrcrecordid>eNrjZLB39vcN8A_1cwlW8PTz8HTyDPH0c1fwcQ119vRz1Q3ydPZQCHINcHUMUfD29HMMdlVw9YuK9HVVcHQO8QzzDInkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFGlmYmRkaGjibGRCgBAE18Kj4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY</title><source>esp@cenet</source><creator>DAI, XING ; GRESHOCK, THOMAS ; STEVENSON, HEATHER ; LIU, HONG ; SANDERS, JOHN ; MILLER, MICHAEL ; MCCAULEY, JOHN, A ; KERN, JONATHAN ; HARRIS, JOEL, M ; BASU, KALLOL ; SCOTT, JACK ; DEMONG, DUANE ; STAMFORD, ANDREW, W ; POIRIER, MARC ; NEUSTADT, BERNARD</creator><creatorcontrib>DAI, XING ; GRESHOCK, THOMAS ; STEVENSON, HEATHER ; LIU, HONG ; SANDERS, JOHN ; MILLER, MICHAEL ; MCCAULEY, JOHN, A ; KERN, JONATHAN ; HARRIS, JOEL, M ; BASU, KALLOL ; SCOTT, JACK ; DEMONG, DUANE ; STAMFORD, ANDREW, W ; POIRIER, MARC ; NEUSTADT, BERNARD</creatorcontrib><description>The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160831&amp;DB=EPODOC&amp;CC=EP&amp;NR=2964221A4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160831&amp;DB=EPODOC&amp;CC=EP&amp;NR=2964221A4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAI, XING</creatorcontrib><creatorcontrib>GRESHOCK, THOMAS</creatorcontrib><creatorcontrib>STEVENSON, HEATHER</creatorcontrib><creatorcontrib>LIU, HONG</creatorcontrib><creatorcontrib>SANDERS, JOHN</creatorcontrib><creatorcontrib>MILLER, MICHAEL</creatorcontrib><creatorcontrib>MCCAULEY, JOHN, A</creatorcontrib><creatorcontrib>KERN, JONATHAN</creatorcontrib><creatorcontrib>HARRIS, JOEL, M</creatorcontrib><creatorcontrib>BASU, KALLOL</creatorcontrib><creatorcontrib>SCOTT, JACK</creatorcontrib><creatorcontrib>DEMONG, DUANE</creatorcontrib><creatorcontrib>STAMFORD, ANDREW, W</creatorcontrib><creatorcontrib>POIRIER, MARC</creatorcontrib><creatorcontrib>NEUSTADT, BERNARD</creatorcontrib><title>COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY</title><description>The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLB39vcN8A_1cwlW8PTz8HTyDPH0c1fwcQ119vRz1Q3ydPZQCHINcHUMUfD29HMMdlVw9YuK9HVVcHQO8QzzDInkYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFGlmYmRkaGjibGRCgBAE18Kj4</recordid><startdate>20160831</startdate><enddate>20160831</enddate><creator>DAI, XING</creator><creator>GRESHOCK, THOMAS</creator><creator>STEVENSON, HEATHER</creator><creator>LIU, HONG</creator><creator>SANDERS, JOHN</creator><creator>MILLER, MICHAEL</creator><creator>MCCAULEY, JOHN, A</creator><creator>KERN, JONATHAN</creator><creator>HARRIS, JOEL, M</creator><creator>BASU, KALLOL</creator><creator>SCOTT, JACK</creator><creator>DEMONG, DUANE</creator><creator>STAMFORD, ANDREW, W</creator><creator>POIRIER, MARC</creator><creator>NEUSTADT, BERNARD</creator><scope>EVB</scope></search><sort><creationdate>20160831</creationdate><title>COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY</title><author>DAI, XING ; GRESHOCK, THOMAS ; STEVENSON, HEATHER ; LIU, HONG ; SANDERS, JOHN ; MILLER, MICHAEL ; MCCAULEY, JOHN, A ; KERN, JONATHAN ; HARRIS, JOEL, M ; BASU, KALLOL ; SCOTT, JACK ; DEMONG, DUANE ; STAMFORD, ANDREW, W ; POIRIER, MARC ; NEUSTADT, BERNARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2964221A43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>DAI, XING</creatorcontrib><creatorcontrib>GRESHOCK, THOMAS</creatorcontrib><creatorcontrib>STEVENSON, HEATHER</creatorcontrib><creatorcontrib>LIU, HONG</creatorcontrib><creatorcontrib>SANDERS, JOHN</creatorcontrib><creatorcontrib>MILLER, MICHAEL</creatorcontrib><creatorcontrib>MCCAULEY, JOHN, A</creatorcontrib><creatorcontrib>KERN, JONATHAN</creatorcontrib><creatorcontrib>HARRIS, JOEL, M</creatorcontrib><creatorcontrib>BASU, KALLOL</creatorcontrib><creatorcontrib>SCOTT, JACK</creatorcontrib><creatorcontrib>DEMONG, DUANE</creatorcontrib><creatorcontrib>STAMFORD, ANDREW, W</creatorcontrib><creatorcontrib>POIRIER, MARC</creatorcontrib><creatorcontrib>NEUSTADT, BERNARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAI, XING</au><au>GRESHOCK, THOMAS</au><au>STEVENSON, HEATHER</au><au>LIU, HONG</au><au>SANDERS, JOHN</au><au>MILLER, MICHAEL</au><au>MCCAULEY, JOHN, A</au><au>KERN, JONATHAN</au><au>HARRIS, JOEL, M</au><au>BASU, KALLOL</au><au>SCOTT, JACK</au><au>DEMONG, DUANE</au><au>STAMFORD, ANDREW, W</au><au>POIRIER, MARC</au><au>NEUSTADT, BERNARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY</title><date>2016-08-31</date><risdate>2016</risdate><abstract>The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK-2 kinase is involved.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2964221A4
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T10%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAI,%20XING&rft.date=2016-08-31&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2964221A4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true